Phase I Trial of Dose-Escalated Five-Fraction Stereotactic Ablative Radiotherapy for Early-Stage Lung Squamous Cell Carcinoma.
Saved in:
| Title: | Phase I Trial of Dose-Escalated Five-Fraction Stereotactic Ablative Radiotherapy for Early-Stage Lung Squamous Cell Carcinoma. |
|---|---|
| Authors: | Shiue, K.1 (AUTHOR), Cerra-Franco, A.2 (AUTHOR), Verma, V.3 (AUTHOR), Arbab, M.1 (AUTHOR), Langer, M.P.1 (AUTHOR), Deig, C.4 (AUTHOR), II, M.E. Tharp5 (AUTHOR), Anthony, P.A.5 (AUTHOR), Shan, M.6 (AUTHOR), Althouse, S.7 (AUTHOR), Zang, Y.6 (AUTHOR), Bartlett, G.K.8 (AUTHOR), Holmes, J.A.1 (AUTHOR), DesRosiers, C.2 (AUTHOR), Maxim, P.G.9 (AUTHOR), Frye, D.1 (AUTHOR), Kong, F.M.10 (AUTHOR), Jin, J.Y.11 (AUTHOR), Watson, G.12 (AUTHOR), Zellars, R.C.13 (AUTHOR) |
| Source: | International Journal of Radiation Oncology, Biology, Physics. 2021 Supplement, Vol. 111 Issue 3, pe451-e451. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 03603016 |
|---|---|
| DOI: | 10.1016/j.ijrobp.2021.07.1270 |
